CIK 0001678660 · Non-accelerated filer<br>Smaller reporting company
Prelude Therapeutics Inc
Sign in to watch- Ticker
- PRLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811384762
- Phone
- (302) 467-1280
- Business address
- 175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
- Former names
- Prelude Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-05 | Sandor Victor Director | Grant or award · Director Stock Option (Right to Buy) | +121,285 | 121,285 | ||
| 2025-10-17 | Dorton Katina Director | Grant or award · Director Stock Option (Right to Buy) | +76,000 | 76,000 | ||
| 2025-10-04 | Huang Jane President, CMO | Option exercise | +9,375 | 90,272 | ||
| 2025-10-04 | Huang Jane President, CMO | Shares withheld for taxes | −3,355 | $1.47 | $5K | 86,917 |
| 2025-10-04 | Huang Jane President, CMO | Option exercise · Restricted Stock Unit | −9,375 | 18,750 | ||
| 2025-07-04 | Huang Jane President, CMO | Option exercise | +9,375 | 84,252 | ||
| 2025-07-04 | Huang Jane President, CMO | Shares withheld for taxes | −3,355 | $0.79 | $3K | 80,897 |
| 2025-07-04 | Huang Jane President, CMO | Option exercise · Restricted Stock Unit | −9,375 | 28,125 | ||
| 2025-06-12 | Sandor Victor Director | Grant or award · Director Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2025-06-12 | Dier Mardi Director | Grant or award · Director Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2025-06-12 | FRIEDMAN PAUL A Director | Grant or award · Director Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2025-06-12 | Bonita David P Director | Grant or award · Director Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2025-06-12 | Babler Martin Director | Grant or award · Director Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2025-06-12 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +76,000 | 76,000 | ||
| 2025-06-12 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +76,000 | 76,000 | ||
| 2025-04-04 | Huang Jane President, CMO | Option exercise | +9,375 | 78,232 | ||
| 2025-04-04 | Huang Jane President, CMO | Shares withheld for taxes | −3,355 | $0.68 | $2K | 74,877 |
| 2025-04-04 | Huang Jane President, CMO | Option exercise · Restricted Stock Unit | −9,375 | 37,500 | ||
| 2025-03-25 | Combs Andrew Chief Chemistry Officer | Purchase | +100,000 | $0.69 | $69K | 480,123 |
| 2025-03-25 | Vaddi Krishna CEO | Purchase | +675,000 | $0.69 | $467K | 1,999,296 |
Page 2 of 8 · 141 trades